We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Tag: screening
MedXY News
EnglishTag

screening

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationbiomarkerscritical careclinical trialsHypertensionartificial intelligenceCardiologyoncologypublic healthtype 1 diabetesdiabetesMortalityAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Tag

New International Consensus: Colorectal Cancer Risk in MASLD — What Clinicians Need to Know
GastroenterologyMASLDmetabolic disease

New International Consensus: Colorectal Cancer Risk in MASLD — What Clinicians Need to Know

By MedXY|Sep 15, 2026

An international Delphi panel concludes metabolic dysfunction‑associated steatotic liver disease (MASLD) raises colorectal cancer (CRC) risk. Experts call for earlier, risk‑adapted CRC screening and integrated metabolic care to reduce CRC b

New International Consensus: Screening the General Population for Islet Autoantibodies to Detect Early-Stage Type 1 Diabetes
Diabetes & EndocrinologyIslet Autoantibodiestype 1 diabetes
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story

New International Consensus: Screening the General Population for Islet Autoantibodies to Detect Early-Stage Type 1 Diabetes

By MedXY|Sep 13, 2026

An international expert consensus recommends practical principles and minimum requirements for general‑population screening for islet autoantibodies to detect early-stage type 1 diabetes, reduce DKA, enable early care and access to disease‑

MDADI Composite Score Thresholds for Efficient Screening of Swallowing Impairment in Head and Neck Cancer Patients
newsDysphagiavideofluoroscopic swallow study

MDADI Composite Score Thresholds for Efficient Screening of Swallowing Impairment in Head and Neck Cancer Patients

By MedXY|Aug 27, 2026

This study validates the MD Anderson Dysphagia Inventory (MDADI) as a reliable screening tool for VFSS-graded swallowing impairment in head and neck cancer patients and proposes a concise four-item version to optimize clinical utility.

Incidental Emphysema Detected on Routine Screening Chest CT and Its Association with Mortality in a Korean Population
newsChest CTsmoking

Incidental Emphysema Detected on Routine Screening Chest CT and Its Association with Mortality in a Korean Population

By MedXY|Aug 24, 2026

This study evaluates the independent association between incidental emphysema found on routine screening chest CT scans and all-cause mortality in a large Korean cohort, highlighting implications for risk stratification among ever-smokers.

Unmasking Silent Heart Failure in Diabetes: Insights from the TARTAN-HF Trial
CardiologydiabetesHFpEF

Unmasking Silent Heart Failure in Diabetes: Insights from the TARTAN-HF Trial

By MedXY|Aug 21, 2026

The TARTAN-HF trial demonstrated that targeted natriuretic peptide screening in high-risk diabetic patients uncovers a high prevalence of undiagnosed heart failure, mainly HFpEF, enabling earlier treatment initiation and improved clinical c

Comparative Performance of Four AI Systems for Detecting Referable Diabetic Retinopathy in Tanzania: A Real-World Evaluation
AIlow-resource settingsretinopathy đái tháo đường

Comparative Performance of Four AI Systems for Detecting Referable Diabetic Retinopathy in Tanzania: A Real-World Evaluation

By MedXY|Aug 12, 2026

This study evaluates four commercially available AI systems for diabetic retinopathy screening in Tanzania, demonstrating high sensitivity for referable and proliferative DR and highlighting considerations for implementation in low-resource

Risk-Guided Screening for Atrial Fibrillation Using Electronic Health Records
Cardiologyatrial fibrillationElectronic Health Records

Risk-Guided Screening for Atrial Fibrillation Using Electronic Health Records

By MedXY|Jul 30, 2026

A machine learning model using electronic health records effectively identifies patients at high risk of atrial fibrillation, enabling targeted screening and early diagnosis to prevent stroke.

Hepatitis C Screening Among Persons Experiencing Homelessness in Emergency Departments: Insights from the DETECT Hep C Screening Trial and Related Evidence
Clinical Updatesemergency departmentHepatitis C

Hepatitis C Screening Among Persons Experiencing Homelessness in Emergency Departments: Insights from the DETECT Hep C Screening Trial and Related Evidence

By MedXY|Jul 17, 2026

Emergency departments serve as vital venues for hepatitis C virus screening, particularly for persons experiencing homelessness who exhibit higher HCV prevalence and face healthcare access barriers. Evidence supports nontargeted screening i

Advancing Early Detection of Nasopharyngeal Carcinoma: Evaluating the Novel Anti-BNLF2b Antibody Test
newsbiomarkersearly detection

Advancing Early Detection of Nasopharyngeal Carcinoma: Evaluating the Novel Anti-BNLF2b Antibody Test

By MedXY|Jul 11, 2026

This article critically appraises a multicenter study validating the Anti-BNLF2b antibody (P85-Ab) assay, highlighting its superior sensitivity and specificity for early nasopharyngeal carcinoma detection compared to established EBV-based b

Symptom Prevalence in Lung Cancer Screening: Insights from the SUMMIT Study
newsĐánh giá rủi rolow-dose CT

Symptom Prevalence in Lung Cancer Screening: Insights from the SUMMIT Study

By MedXY|Jul 2, 2026

The SUMMIT study reveals that respiratory symptoms are common among lung cancer screening participants and associated with increased lung cancer diagnosis risk within one year, challenging conventional asymptomatic screening definitions.

Enhanced Detection of Clinically Significant Prostate Cancer: Insights from the Stockholm3-MRI Screening Study Two-Year Follow-up
newsClinically Significant CancerMRI

Enhanced Detection of Clinically Significant Prostate Cancer: Insights from the Stockholm3-MRI Screening Study Two-Year Follow-up

By MedXY|Jun 25, 2026

The Stockholm3 test combined with MRI screening significantly improves detection of clinically significant prostate cancer compared to PSA alone, reducing missed cases and unnecessary biopsies in a population-based study with 2-year follow-

Validated Early Detection Metrics Could Narrow Liver Fibrosis Screening Without Losing Clinical Signal
Gastroenterologyliver fibrosispublic health

Validated Early Detection Metrics Could Narrow Liver Fibrosis Screening Without Losing Clinical Signal

By MedXY|Jun 19, 2026

A validation study suggests current liver fibrosis screening criteria are too broad. A refined risk-based approach reduced eligibility from 60–76% to 10–22% of adults while improving the yield of elevated liver stiffness and predicting futu

Your Nose Knows: How Smell Loss Signals More Than a Cold — Links to 139 Diseases and What to Do About It
Neurologyneurologyolfaction

Your Nose Knows: How Smell Loss Signals More Than a Cold — Links to 139 Diseases and What to Do About It

By MedXY|Dec 13, 2025

A large prospective study links smell disturbances to at least 139 conditions. Olfactory loss can be an early sign of neurological, ENT, metabolic, or systemic disease — and a practical, underused screening tool clinicians can adopt.

AI-Enhanced ECG Predicts Future Regurgitant Valvular Disease: Large International Study Shows Promise for Earlier Detection and Targeted Echocardiography
AIAI-ECGMitral Regurgitation

AI-Enhanced ECG Predicts Future Regurgitant Valvular Disease: Large International Study Shows Promise for Earlier Detection and Targeted Echocardiography

By MedXY|Dec 1, 2025

An international study developed AI-ECG models that diagnose and predict future moderate–severe mitral, tricuspid, and aortic regurgitation, validated across distinct populations and linked to subclinical chamber remodelling.

AI-Augmented Screening Triples Detection Yield of Transthyretin Cardiac Amyloidosis in a Multisite Real-World Trial
AIartificial intelligenceATTR-CM

AI-Augmented Screening Triples Detection Yield of Transthyretin Cardiac Amyloidosis in a Multisite Real-World Trial

By MedXY|Nov 18, 2025

An AI-driven screening program (ATTRACTnet) applied to ECG, echocardiography, demographics and orthopedic history substantially increased case detection of transthyretin cardiac amyloidosis (ATTR‑CM) and led to rapid treatment initiation in

Metformin Selectively Lowers Vitamin B12 but Not Other Vitamin Levels: Clinical Implications for Long-Term Therapy
Diabetes & Endocrinologydiabetesmetformin

Metformin Selectively Lowers Vitamin B12 but Not Other Vitamin Levels: Clinical Implications for Long-Term Therapy

By MedXY|Nov 17, 2025

A 200‑patient cross‑sectional study found metformin use tripled the odds of vitamin B12 deficiency without affecting vitamins A, B1, B6, B9, C or E, highlighting the need for targeted B12 monitoring in long‑term metformin therapy.

Screening Children and Young Adults for Familial Hypercholesterolemia: Clinically Helpful but Not Cost‑Effective
CardiologyCost-EffectivenessHypercholesterolemia

Screening Children and Young Adults for Familial Hypercholesterolemia: Clinically Helpful but Not Cost‑Effective

By MedXY|Nov 10, 2025

A modeling study found that sequential population screening for familial hypercholesterolemia (FH) at ages 10 or 18 is clinically effective but not cost‑effective versus usual care, unless follow-up monitoring and lifestyle interventions fo

High Burden of ARFID Symptoms in Adults with Disorders of Gut–Brain Interaction: A Population-Based Study Signals Need for Routine Screening
GastroenterologyARFIDscreening

High Burden of ARFID Symptoms in Adults with Disorders of Gut–Brain Interaction: A Population-Based Study Signals Need for Routine Screening

By MedXY|Nov 10, 2025

A 2023 population survey of 4,002 adults in the UK and US found that positive screens for avoidant/restrictive food intake disorder (ARFID) were common among people with disorders of gut–brain interaction (DGBI) and associated with greater

Cutting the Curve: Consensus Strategies to Reduce Alcohol‑Associated Liver Disease in the Population
Gastroenterologyalcohol-associated liver diseaseFIB-4

Cutting the Curve: Consensus Strategies to Reduce Alcohol‑Associated Liver Disease in the Population

By MedXY|Nov 9, 2025

A concise synthesis of a 2025 multistakeholder Lancet workshop consensus on population and clinical strategies to prevent, detect, and manage alcohol‑associated liver disease.

Taipei Global Consensus II (2025): A Practical Guide to Helicobacter pylori Screening and Eradication for Gastric Cancer Prevention
GastroenterologyguidelineHelicobacter pylori

Taipei Global Consensus II (2025): A Practical Guide to Helicobacter pylori Screening and Eradication for Gastric Cancer Prevention

By MedXY|Nov 7, 2025

An evidence-based synthesis of the 2025 Taipei Global Consensus II: 28 statements guiding H. pylori screening, eradication, surveillance and stewardship to reduce gastric cancer at individual and population levels.

1 / 2
12
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities